CTSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cytosorbents Corp (CTSO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive trading signals, weak financial performance, and absence of strong catalysts suggest holding off on investing until clearer growth indicators or positive trends emerge.
The MACD is slightly positive and expanding, indicating mild bullish momentum. However, RSI is neutral, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5), suggesting a downtrend. The stock is trading near its pivot level of 0.597, with resistance at 0.646 and support at 0.548.
Revenue increased by 41.56% YoY in Q4 2025, showing some growth potential.
Net income dropped by -30.28% YoY, EPS declined by -35.71% YoY, and gross margin fell by -29.02% YoY. No recent news or significant trading trends from hedge funds, insiders, or Congress. The stock has an 80% chance of declining -5.1% in the next month.
In Q4 2025, revenue grew by 41.56% YoY to $9,234,000. However, net income dropped to -$5,497,000 (-30.28% YoY), EPS declined to -0.09 (-35.71% YoY), and gross margin decreased to 73.68% (-29.02% YoY).
No recent analyst ratings or price target changes are available for CTSO.
